Aammaad Shams - 01 Mar 2022 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Controller
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
01 Mar 2022
Net transactions value
-$44,196
Form type
4
Filing time
03 Mar 2022, 20:28:19 UTC
Next filing
04 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +6,250 +42% $0.000000 21,250 01 Mar 2022 Direct F1, F2, F3
transaction EVH Class A Common Stock Tax liability $44,196 -1,613 -7.6% $27.40 19,637 01 Mar 2022 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to Mr. Shams pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2 Securities vest at a rate of 34% on March 1, 2023, and 33 % on March 1, 2024, and March 1, 2025.
F3 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F4 This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.